Why ImmunityBio’s UAE authorization gives ANKTIVA a broader cancer label than it has in the United States
ImmunityBio gains UAE authorization for ANKTIVA in broader bladder cancer and metastatic lung cancer uses, widening its Gulf commercial opportunity.